Information technology firm CA Inc. will pay $45 million to resolve allegations that it made false statements and claims in connection with a U.S. government contract, the Justice Department said Friday.
Entries in False Claims Act (75)
A physician who alleged in a federal whistleblower lawsuit that his former employer encouraged employees to overbill federal programs for higher and more expensive levels of medical service than were actually performed will collect about $11.4 million.
The DOJ Thursday settled a case with a pharma company accused of paying doctors illegal speaking fees.
Two doctors who alleged in a lawsuit filed under the False Claims Act that another doctor at a Florida not-for-profit hospital was performing unnecessary cardiac procedures and studies were awarded $2.7 million Wednesday as part of a $12 million settlement.
A marketing executive who alleged in a whistleblower lawsuit that a medical device maker lied to the U.S. Food and Drug Administration (FDA) was awarded $5.1 million this week.
Two former employees of a company that operates a chain of skilled nursing facilities across the country were awarded $29 million as part of a False Claims Act settlement.
A former saleswoman for medical device maker Acclarent was awarded $3.5 million as her share of an $18 million settlement of a whistleblower suit alleging false marketing claims.
A former Genentech product manager who alleged his company exaggerated the effectiveness of the drug Tarceva to treat lung cancer will collect more than $10 million as part of a False Claims Act settlement.
A cardiac nurse and a healthcare reimbursement consultant are splitting $3.5 million as their share of a $23 million settlement by 51 hospitals that allegedly violated Medicare coverage rules about implanting heart defibrillation devices in patients.
The biggest doctor-led cancer care provider in the United States and a Florida subsidiary paid $34.7 million Tuesday to resolve whistleblower allegations they performed and billed for procedures that weren't medically necessary.
First-hand details of the global pay to play kickback scheme at Olympus were brought to the government's attention by the company's former corporate compliance officer.